Johanne Kaplan
Corporate Officer/Principal bei PROMIS NEUROSCIENCES, INC.
Vermögen: 12 065 $ am 31.03.2024
Profil
Johanne Kaplan is currently the Chief Development Officer at ProMIS Neurosciences, Inc. She previously worked as an Associate at Smithkline Beecham Plc from 1990 to 1992, as Vice President-Research at Genzyme Corp.
from 2005 to 2015, and as Chief Scientific Officer at Epiva Biosciences, Inc. from 2015 to 2016.
Kaplan earned a doctorate degree from McGill University in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.10.2023 | 6 317 ( 0,03% ) | 12 065 $ | 31.03.2024 |
Aktive Positionen von Johanne Kaplan
| Unternehmen | Position | Beginn |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Corporate Officer/Principal | 21.07.2016 |
Ehemalige bekannte Positionen von Johanne Kaplan
| Unternehmen | Position | Ende |
|---|---|---|
Epiva Biosciences, Inc.
 Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.05.2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.07.2015 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | 01.06.1992 |
Ausbildung von Johanne Kaplan
| McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Epiva Biosciences, Inc.
Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Health Technology |
